Why Most Dogs with Bladder Cancer Are Euthanized: A Revealing Study Sheds Light
Involving 59 dogs diagnosed with UC, this retrospective study scrutinized the clinical signs and circumstances surrounding euthanasia after treatments like radiation therapy and chemotherapy. The results were telling: the median survival time for these canine patients was just under a year. Astonishingly, 85% of these dogs were euthanized due to complications directly related to their cancer, with a staggering 62% suffering from local tumor progression leading to complete or partial urinary obstruction.
Revolutionary Cancer Treatment for Cats Leaves Vets Astonished
In the realm of veterinary medicine, a groundbreaking approach has emerged, offering new hope in the fight against one of the most daunting adversaries: feline cancer. Specifically, basal cell tumors, including the common basal cell carcinomas and the rarer basosquamous carcinomas found on or near the nasal planum in cats, have met their match with electrochemotherapy (ECT), including a novel method known as calcium electroporation. This cutting-edge treatment has been successfully deployed in managing these malignancies in three cats, marking a significant breakthrough in veterinary oncology.
Is This the Breakthrough Cure for Dog Cancer We've Been Waiting For? Cornell's New Study Sparks Hope
In a groundbreaking trial that's catching the eyes of pet owners and veterinarians alike, the Cornell University Hospital for Animals (CUHA) is on the brink of a medical breakthrough that could change the way we treat one of the most aggressive cancers in dogs: oral squamous cell carcinoma (OSCC). This cancer, notorious for its rapid progression and devastating impact on dogs' jaws and overall health, might finally meet its match in a new drug treatment that promises to be less invasive and more hopeful than the current, often disheartening surgical options.
Revolutionizing Cancer Treatment: Canine Study Unlocks Secrets of Aggressive T-Cell Lymphoma!
A groundbreaking study has shed new light on the gene expression profile and cellular origins of canine peripheral T-cell lymphoma (PTCL), offering promising insights for both veterinary and human medicine. PTCL, a diverse group of T-cell cancers notorious for poor treatment responses, finds a parallel in the most common human subtype, PTCL-not otherwise specified (PTCL-NOS). This similarity has spurred interest in canine PTCL as a potential model for human PTCL research.
Mind-Blowing breakthrough: Canine cancer treatment that astonished even experts!
In human medicine, intrathecal chemotherapy is a well-known treatment for central nervous system hematopoietic neoplasia. However, its application and benefits in veterinary medicine remain relatively unexplored. In this case report, we delve into the story of a 4-year-old male cross-breed dog who presented with concerning symptoms, leading to an intriguing use of intrathecal chemotherapy.
BREAKING: New cancer drug holds hope for man's best friend - Could this be the cure we've been waiting for?
A groundbreaking multi-center clinical trial funded by the Bernese Mountain Dog Club of America is set to evaluate the potential of a cancer drug to control tumor growth and improve outcomes for dogs with histiocytic sarcoma, a typically fatal canine cancer. Dr. Vilma Yuzbasiyan-Gurkan, the study's Principal Investigator, shares her excitement about the targeted approach using the drug trametinib, showing promising results in tests against canine sarcoma cell lines and mouse models.